Comment on "Pre-hospital antiplatelet medication use on COVID-19 disease severity"

Heart Lung. 2022 Sep-Oct:55:164-165. doi: 10.1016/j.hrtlng.2022.04.020. Epub 2022 May 2.

Authors

Arsalan Nadeem¹, Zoya Ejaz²

Affiliations

¹ Department of Medicine, Allama Iqbal Medical College, Lahore, Pakistan. Electronic address: arsalannadeemh@gmail.com.
² Department of Medicine, Allama Iqbal Medical College, Lahore, Pakistan. Electronic address: zoyaejaz171@gmail.com.

No abstract available

Keywords: Antiplatelet; COVID-19; D-dimer; Ethnicity; Mortality.

Publication types

Letter
Comment

MeSH terms

COVID-19*
Hospitals
Humans
Platelet Aggregation Inhibitors / therapeutic use
SARS-CoV-2
Severity of Illness Index

Substances

Platelet Aggregation Inhibitors